FDA Approves Liquid Biopsy Tests
The U.S. Food and Drug Administration (FDA) has approved the usage of the Guardant360 CDx and FoundationOne Liquid CDx liquid biopsy tests for a number of solid tumors. The biopsies will be conducted via the blood, hence making them less painful, and more accessible....
Clinical Trials During COVID-19: A Glimpse into a Healthier World
While COVID-19 has caused many interruptions across industries, the drug development and supply chain has experienced some of the most severe repercussions. With potential exposure to the virus limiting number of trial participants, as well as site staff and...
NMPA Approves Adalimumab Injection SULINNO® for Arthritis Treatment
Biopharmaceutical company Innovnet Biologics, Inc. announced today (9/3) that the National Medical Products Administration (NMPA) has approved SULINNO®, an adalimumab injection, for rheumatoid arthritis, ankylosing spondylitis and psoriasis treatment in China....
California Passes Bill to Claim Ownership of Prescription Drugs
On Monday (8/31), a bill was passed in California, with 32 in favor and 7 against, to redistribute the state’s market power to make prescription drugs more affordable and accessible. The COVID-19 pandemic has been said to act as proof that improvements must be made to...
FDA Approves Expansion of Remdesivir for Hospitalized COVID-19 Patients
Gilead, a research-based biopharmaceutical company, has reported that their new antiviral treatment for COVID-19 Remdesivir, has just been granted an expansion on emergency use authorization (EUA) by the FDA for all patients hospitalized due to COVID-19. Originally...
FDA Grants Approval to Laurent Pharmaceuticals to Start COVID-19 Phase 2 Clinical Trial in the United States
Laurent Pharmaceuticals, a Montreal based clinical stage biopharmaceutical company has come up with an oral drug candidate, LAU-7b, to potentially treat COVID-19. The U.S. Food and Drug Administration (FDA) has granted Laurent Pharmaceuticals to begin enrolling U.S....
Transcreation: Marketing Translations for Life Science Industries
Marketing translations is a vital step across all industries. With so many different cultures affecting global markets, it’s important to present branding messages in a way that is culturally sensitive as well as linguistically accurate for product’s or service’s...
RenalytixAI FDA Clearence for New Kidney Treatment Technology
RenalytixAI, an in vitro diagnostics that uses artificial intelligence, has filed a submission to the FDA to clear new kidney treatment called KidneyIntelx. KidneyIntelx is designed to optimize clinical management and patient outcomes of kidney disease research as...
EPA Grants Emergency Approval for Antiviral Coating to be Used for American Airlines
American Airlines has been given approval by the U.S. Environmental Protection Agency (EPA) to use a COVID-19 disinfectant on surfaces throughout the airplanes. The virus-killing spray is effective on surfaces for up to seven days, and the EPA is studying whether this...
Lowering Prescription Drug Prices for Affordability and Accessibility for US Citizens
One of the biggest areas of concern in the pharmaceutical industry, particularly in the United States, is the high costs of new treatments or drug therapies for patients. The recent initiatives from regulatory agencies like the Food and Drug Administration (FDA) to...
Health Canada Implements ICH Pediatric Drug Development Guidance
Health Canada has adopted a nonclinical safety testing guidance to help develop medication in pediatrics. This guidance called GuidanceS11: Nonclinical Safety Testing in Support of Development of Pediatric Medicines has been developed by the ICH and is slated to be...
FDA Rejects Gilead’s Rheumatoid Arthritis New Drug Application
Gilead submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for filgotnib, a treatment for rheumatoid arthritis, which the FDA rejected due to safety concerns, particular in the 200mg dose. “We are disappointed in this outcome and will...
FDA Propose Non-Invasive Bone Grown Stimulators Reclassifying from Class III to Class II
The US Food and Drug Administration (FDA) proposed reclassifying non-invasive bone grown stimulators from Class III to Class II, reducing the regulatory burdens and allowing the devices to be marketed with 501(k) clearance rather than requiring premarket...
Rare Disease Stakeholders Demand Regulatory Clarity
The Food and Drug Administration (FDA) asked for rare disease stakeholders, including individuals and families affected by rare disease(s), pharmaceutical companies, trade associations, and other federal agencies and regulators, to weigh in on a proposed clinical...
The Importance of Regulatory Translation in the Life Sciences
For businesses in the life sciences looking to globalize their product or service, accurate and high-quality regulatory translation is essential for market access and success. Companies creating innovative, lifesaving or life enhancing drug therapies and devices,...
Linguistic Validation: What You Need to Know
Linguistic validation is a technique of reviewing and validating the accuracy, reliability, and equivalency for measurements of patient-reported outcomes (PROs). These outcomes, directly reported by patients, help determine the usefulness and efficacy of various...
Russia Announces Approval of COVID-19 Vaccine
Vladimir Putin announced on yesterday (8/11) of Russia’s approval for COVID-19 vaccine, “Sputnik V”. The approval comes before the vaccine has completed its final stages in the clinical trials, causing worry from both inside and outside the country. The first round of...
FDA Provides New Guidance for Drug-Drug Interaction Studies of Therapeutic Proteins
The US Federal Drug Administration (FDA) with the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER) has provided guidance today (8/10) for drug-drug interaction studies of therapeutic proteins. The guidance...
How Technology is Enabling Patients’ Voices to be Heard in Clinical Research
COVID-19 has forced most of the world to work remotely, causing a major disruption in clinical research and the drug development process. As a result, the need for centralized and advanced patient engagement technology to better healthcare for all parties involved,...
Pfizer Signs Multiyear Agreement to Make Gilead’s Covid Treatment Remdesivir
Pfizer announced today (8/7) that it has signed a multiyear agreement for Gilead’s remdesivir, a treatment for Covid. With Gilead aiming to produce enough remdesivir to treat more than 2 million patients by the end of the year, and agreeing to send almost the entirety...